London: Researchers from Cincinnati Children’s Hospital Medical Center have identified the key culprit behind severe asthma-like symptoms in mice.The disease can be triggered in susceptible people by a variety of environmental contaminants – such as cigarette smoke, allergens and airborne pollution.Dr. Marsha Wills-Karp and her colleagues have identified the pro-inflammatory protein, interleukin-17 (IL-17A), as the molecular tipping point that upsets a delicate balance between underlying mild disease and more severe asthma, reports Nature.
As the team continues their research, they will study the relationship between C3 and IL-17A in severe asthmatics, and explore the effectiveness of targeting either the C3 or IL-17A pathways for the treatment of severe asthma.The study is published in the latest Nature Immunology. ANI
Treatment for spine problems through sound waves
New hope for restoring hearing loss in adults